| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| eFFECTOR Therapeutics, Inc. | Chief Business Officer | Stock Option (Right to Buy) | 150,000 | 17 Jan 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000120919123004048-gandhi-mayank-2023-01-17 | eFFECTOR Therapeutics, Inc. | 17 Jan 2023 | 1 | $0 | 4 | Chief Business Officer | 19 Jan 2023, 16:04 |
| /report/000120919122051466-gandhi-mayank-2022-09-26 | eFFECTOR Therapeutics, Inc. | 26 Sep 2022 | 1 | $0 | 4 | Chief Business Officer | 28 Sep 2022, 16:47 |
| /report/000120919122051464-gandhi-mayank-2022-09-26 | eFFECTOR Therapeutics, Inc. | 26 Sep 2022 | 0 | $0 | 3 | Chief Business Officer | 28 Sep 2022, 16:43 |